Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks

This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI ...